Intravenous Thrombolysis after Reversal of Dabigatran by Idarucizumab: A Case Report

We describe a 75-year-old female patient with nonvalvular atrial fibrillation who presented with acute ischemic stroke during treatment with dabigatran 2 × 110 mg per day. After informed consent, we reversed the anticoagulant effects of dabigatran using idarucizumab and applied an intravenous thromb...

Descripción completa

Detalles Bibliográficos
Autores principales: Kafke, Waldemar, Kraft, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945814/
https://www.ncbi.nlm.nih.gov/pubmed/27482196
http://dx.doi.org/10.1159/000447531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945814/
https://www.ncbi.nlm.nih.gov/pubmed/27482196
http://dx.doi.org/10.1159/000447531

Ejemplares similares